Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
‘Unauthorized Alien’ Limits Among Trio of Auto Insurance Proposals Under Consideration in LA House Three auto insurance bills cleared the Louisiana House Committee on Civil Law and Procedure...
Social Media Bill Dodges Veto Override in CO Colorado Gov. Jared Polis’ (D) veto of a social media bill ( SB 86 ) survived an override attempt. The state’s Democrat-controlled Senate voted...
WA Enacts Law Keeping Medical Debt Off Credit Reports Washington Gov. Bob Ferguson (D) signed a bill ( SB 5480 ) prohibiting collection agencies from reporting unpaid medical debt to credit agencies...
In 2022, there were about 22 maternal deaths for every 100,000 live births in the United States. That’s the highest rate of maternal deaths among high-income nations worldwide. That sobering statistic...
DOGE-Like Effort in FL Could Impact Insurance Industry The wave of housecleaning that’s swept through the federal government courtesy of Elon Musk's Department of Government Efficiency appears...
Federal officials have uncovered significant problems with the systems and procedures states have been employing to “unwind” Medicaid coverage protections put in place during the pandemic. A senior official at the Centers for Medicare and Medicaid Services said many states have been conducting automatic or “ex parte” renewals based on state databases to determine whether residents are still eligible for Medicaid coverage, sending out renewal forms and disenrolling anyone who doesn’t return them. (NEW YORK TIMES)
The Centers for Medicare and Medicaid Services announced the first 10 medications selected for price negotiations with Medicare in accordance with the Inflation Reduction Act, signed by President Biden in August 2022. CMS prioritized drugs that account for the most Medicare spending and came on the market years ago but face little competition. (NEW YORK TIMES)
A group of 11 governors, led by South Dakota Gov. Kristi Noem (R), sent a letter to congressional leaders urging them to take action to address shortages of prescription drugs. Noting that 80% of the active ingredients in prescription drugs come from other countries, mainly China and India, the governors called for policies to "increase diversity in the manufacturing of generic medications with regards to both raw materials and final manufacturing," require greater transparency from the FDA regarding shortages and relax the guidance for medication expiration dates to extend its shelf life. (CENTER SQUARE)
—Compiled by SNCJ Managing Editor KOREY CLARK
Please visit our webpage to connect with a State Net® representative and learn how the State Net legislative and regulatory tracking solution can help you identify, track, analyze and report on relevant legislative and regulatory developments.